Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1
The dire prognosis of pancreatic cancer has not markedly improved during past decades. The present study was carried out to explore the effect of Qingyihuaji formula (QYHJ) on inhibiting pancreatic cancer and prolonging survival in related Notch signaling pathway. Proliferation of pancreatic cancer...
Main Authors: | Yanli Xu, Shan Xu, Yueqin Cai, Luming Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2015/145016 |
Similar Items
-
Retracted: Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1
by: Evidence-Based Complementary and Alternative Medicine
Published: (2021-01-01) -
Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells
by: Song Gao, et al.
Published: (2016-01-01) -
Hey2 functions in parallel with Hes1 and Hes5 for mammalian auditory sensory organ development
by: Chin Michael T, et al.
Published: (2008-02-01) -
Hyperhomocysteinemia induces injury in olfactory bulb neurons by downregulating Hes1 and Hes5 expression
by: Jing-wen Zhang, et al.
Published: (2018-01-01) -
Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma.
by: Christopher D Mann, et al.
Published: (2012-01-01)